Beta-Amyloid Peptides Enhance the Proliferative Response of Activated CD4+CD28+ Lymphocytes from Alzheimer Disease Patients and from Healthy Elderly. This evidence concerns the gene CD28 and early-onset autosomal dominant Alzheimer disease.